Virchow's triad revisited: Abnormal flow

Pathophysiology of Haemostasis and Thrombosis

Volumn 33, Issue 5-6, 2003, Pages 455-457

  Lowe, Gordon D O ^a,b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Blood flow; Endothelial cells; Platelets; Shear stress; Thrombosis

Indexed keywords

FIBRIN; FIBRINOGEN; LOW DENSITY LIPOPROTEIN; MONOMER; NITRIC OXIDE; PROSTACYCLIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ARTERY BLOOD FLOW; ARTERY THROMBOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; BLEEDING; BLOOD FLOW; BLOOD VESSEL WALL; BLOOD VISCOSITY; BRAIN INFARCTION; CARDIOVASCULAR RISK; CARDIOVERSION; CAROTID ARTERY; CELL ACTIVATION; CELL FUNCTION; CELL STRUCTURE; CIRCULATION; CONCENTRATION (PARAMETERS); CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE PREDISPOSITION; ENDOTHELIUM CELL; ERYTHROCYTE; EXERCISE; FLOW KINETICS; FORCE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEMATOCRIT; HEMOSTASIS; INFARCTION; INTIMA; INTRACARDIAC THROMBOSIS; ISCHEMIA; LAMINAR FLOW; LEUKOCYTE; LEUKOCYTE COUNT; LIMB DISEASE; PATHOGENESIS; PLASMA VISCOSITY; PRESSURE; PRIORITY JOURNAL; SHEAR STRESS; SUBENDOTHELIUM; THICKNESS; THROMBOCYTE ACTIVATION; THROMBOCYTE ADHESION; THROMBOEMBOLISM; VEIN THROMBOSIS; VENOUS STASIS; VISCOSITY;

BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HUMANS; ISCHEMIA; REGIONAL BLOOD FLOW; STRESS, MECHANICAL; THROMBOSIS;

EID: 14044270687     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083845     Document Type: Conference Paper

References (21)

1. Lowe GDO. Rheological influences on thrombosis. Bailliere's Clin Haematol 1999;12:435-449.
2. Levesque MJ, Nerem RM. The elongation and orientation of cultured endothelial cells in response to shear stress. J Biochem Engin 1985;107:341-347.
3. Wasserman SM, Topper JN. Adaptation of the endothelium to fluid flow: in vitro analyses of gene expression and in vivo implications. Vasc Med 2004;9:35-45.
4. Lee AJ, Mowbray PI, Lowe GDO, Rumley A, Fowkes FGR, Allan PL. Blood viscosity and elevated carotid intima-media thickness in men and women: the Edinburgh Artery Study. Circulation 1998;97:1467-1473.
5. Lowe GDO, Lee AJ, Rumley A, Price JF, Fowkes FGR. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol 1997;96:168-173.
6. Lowe GDO, Drummond MM, Lorimer AR, Hutton I, Forbes CD, Prentice CRM, Barbenel JC. Relationship between extent of coronary artery disease and blood viscosity. Br Med J 1980;i:673-674.
7. Lowe GDO, Fowkes FGR, Dawes J, Donnan PT, Lennie SE, Housley E. Blood viscosity, fibrinogen and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh Artery Study. Circulation 1993;87:1915-1920.
8. Meade T, Zuhrie R, Cook C, Cooper J on behalf of MRC General Practice Research Framework. Bezafibrate in men with lower extremity arterial disease: randomised controlled trial. Br Med J 2002;325:1139-1143.
9. Mohler ER, Hiatt WR, Creager MA for the Study Investigators. Cholesterol reduction with atrovastatin improves walking distance in patients with peripheral arterial disease. Circulation 2003;208:1481-1486.
10. Lowe GDO, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, Macfarlane P, Packard C. on behalf of the West of Scotland Coronary Prevention Group.
11. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 2000;84:553-558.
12. Ernst E, Matrai A. Intermittent claudication, exercise and blood rheology. Circulation 1987;76:1110-1114.
13. Leng GC, Fowler B, Ernst E. Exercise for intermittent claudication. Cochrane Database Syst Rev 2000;2:CD000990.
14. Wannamethee SG, Lowe GDO, Whincup PH, Rumley A, Walker M, Lennon L. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002;105:1785-1790.
15. Lowe GDO. Blood rheology, haemostasis and vascular disease. In, Bloom, A.L., Forbes, C.D., Thomas, D.P., Tuddenham, E.G.D. (eds): Haemostasis and Thrombosis, 3rd edition. Edinburgh: Churchill Livingstone, 1994, pp 1169-1188.
16. Danesh J, Collins R, Appleby P, Petro R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease. JAMA 1998;279:1477-1482.
17. Danesh J, Collins R, Peto R, Lowe GDO. Haematocrit, viscosity, erthryocyte sedimentation rate: meta-analyses of prospective studies of coronary heart disease. Europ Heart J 2000;21:515-520.
18. Danesh J, Wheeler JG, Hirshfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GDO, Pepys MB, Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Engl J Med 2004;350:1387-1397.
19. Heppell RM, Berkin KE, McLenachan JM, Davies, JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77:407-411.
20. Butchart EG, Bodnar E (eds). Current issues in heart valve disease: Thrombosis, embolism and bleeding. London: ICR Publishers 1992.
21. Lowe GDO. Blood rheology and venous thrombosis. Clinical Haemorheology 1984;4:571-588.